₹15.35
+₹0.23 (+1.52%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹13 Cr
P/E
-13.87
ROE
-59.85%
ROCE
-32.17%
About Ortin Global Ltd
Ortin Global is engaged in the manufacturing and trading of pharmaceuticals, Drugs and Intermediates, to manufacture, sell or export all types of medicines including ayurvedic, homeopathic, unani, biochemical, nature cure, etc and also to engage in real estate
Founded
1986
CEO
Sarang Balbhimrao Patodekar
Employees
3
HQ
Hyderabad, Telangana
About Ortin Global Ltd
Ortin Global is engaged in the manufacturing and trading of pharmaceuticals, Drugs and Intermediates, to manufacture, sell or export all types of medicines including ayurvedic, homeopathic, unani, biochemical, nature cure, etc and also to engage in real estate
Founded:1986
CEO:Sarang Balbhimrao Patodekar
Employees:3
HQ:Hyderabad, Telangana
Finished Products
1Sales
₹2.45CrRaw Materials
1Raw Material Consumed
₹2.38Cr2Purchases
₹0.18CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹21
52W Low
₹11
Volume11.88K
Avg VolumeN/A
Beta0.40
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
-13.87x
Valuation
P/B Ratio
10.09x
Valuation
EPS
₹-1.11
Valuation
Dividend Yield
0.00%
Valuation
ROE
-59.85%
Profitability
ROCE
-32.17%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacture of Pharmaceutical ProduRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.81x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-61.6%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.